RAC (EU) Examination Study Checklist

Similar documents
RAC (Canada) Examination Study Checklist

Di Renzo Regulatory Affairs ROME - MILAN - LONDON

CMDh Best Practice Guide on the processing of renewals in the Mutual Recognition and Decentralised Procedures

COMMISSION RECOMMENDATION. of XXX. on the audits and assessments performed by notified bodies in the field of medical devices

MEDICAL DEVICE. Technical file.

Guideline on the processing of renewals in the centralised procedure

Guideline on the processing of renewals in the centralised procedure

Course Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

Clinical Trials application process, legislation & guidelines

Guide to Scientific and Regulatory Advice for GXP activities

2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)

2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)

RSC/CT Det. no. 1/2013

DIFFERING CMC REQUIREMENTS: US AND EU

EXPERT ISE YOU CAN TRUST

Overview of global registration of vaccines

Conducted Under an IND to Support a

Regulatory Structure, Science and Compliance in a Medical Device Manufacturer. Disclaimer Statement

Regulatory and ethical requirements in medical device studies. Finland

The interface between Good Clinical Practice and Good Manufacturing Practice

Checklist for the assessment based on the standards

Standard Operating Procedure (SOP) Research and Development Office

Qualified Persons in the Pharmaceutical Industry. Code of Practice. March 2008

SUPPLY AND INSTALLATION OF TURBINES AND GENERATORS CONTRACT SCHEDULE 8 QUALITY MANAGEMENT TABLE OF CONTENTS

UNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS

GENERAL AND ORGANISATIONAL REQUIREMENTS

EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL QUESTIONS. and ANSWERS

Quality Assurance of Investigational Medicinal Products. Sue McKenzie PPQA (A)

ISO 13485:2016 Medical Devices-Quality Management Systems- Requirements for Regulatory Purposes. Theresa McCarthy

UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD)

OUR product RUles June 2015

Impact of the MD/IVD Regulations on Quality Management Systems

Effects of the European MDR on the Quality Management System. Karl-Heinz Spohn

QSS 0 Products and Services without Bespoke Contracts.

GxP Inspections within the Centralised Procedure. Brendan Cuddy Inspections Sector

STANDARD OPERATING PROCEDURE FOR RESEARCH. 17. Study Close Down

Data Collection Tools Functions, Indicators & Sub-Indicators

OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS

Bridging gaps: medical device directive vs regulation. Geert Corstens 1 November 2018

UK Standards for Pharmacovigilance Departments 2015

Implementation and Impact of the PV Regulations - how are we doing? Sue Rees Eisai Europe Ltd. & John Barber, Dr Reddy's Laboratories

Quality Management in PV. Andrea Lohée, Pharm-AD DCVMN training on PV, May 2017

Track III: International Clinical Trials: Global Compliance Norms and EU Focus

Guidance for applicants for ethics committee opinion on the conduct of a clinical trial of pharmaceuticals

Inspection of the conduct of clinical evaluations on medical devices in the premises of healthcare providers

Journal of Chemical and Pharmaceutical Research

Regulatory and ethical requirements in medical devices studies. France

CO-ORDINATION OF NOTIFIED BODIES PPE Regulation 2016/425 RECOMMENDATION FOR USE

WELMEC Application of module D Quality assurance Under directive 2014/32/EU (MID) or directive 2014/31/EU (NAWID)

arena that impact on clinical development

GCP Basics - refresher

Guideline on the Regulation of Therapeutic Products in New Zealand

RD SOP32 Gaining MHRA Approval

Authorisation of ATMPs in EU: routes to facilitate prompt availability for patients.

Questionnaire Layout:

Association of American Railroads Quality Assurance System Evaluation (QASE) Checklist Rev. 1/12/2017

University joins Industry: Clinical Trials & Drug Safety. Aula Magna-Facultad de Farmacia 11 Marzo 2015

Legal Obligations of Distributors under the Construction Products Regulation and other Associated European Legislation as from 1 st July 2013

Vaccine Prequalification Dossier

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)

MINISTRY OF HEALTH ORDINANCE

Chain of Custody Standard

elearning Catalog DIAglobal.org/eLearning

SQF Food Safety Code for Manufacturing Changes from Edition 7 to Edition 8

QUESTIONS AND ANSWERS ON THE PAEDIATRIC REGULATION (REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL (EC) No 1901/2006, AS AMENDED)

COMMON MARKET OF MEDICINES OF THE EURASIAN ECONOMIC UNION: RULES OF GOOD CLINICAL PRACTICE AND GOOD LABORATORY PRACTICE

NIS Considerations - Bulgaria

Pharmacovigilance and the Generic Industry

Developing and Implementing a Comprehensive Clinical QA Audit Program

CAREER DEVELOPMENT FOR EXPERIENCED REGULATORY PROFESSIONALS

ANNEX. CHAPTER I General principles

Public Consultation Paper: Assessment of the Functioning of the Clinical Trials Directive 2001/20/EC

In the huge expanse of Asia, Singapore and

1. Council conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States

Guideline on good pharmacovigilance practices (GVP)

FINAL DOCUMENT. Global Harmonization Task Force. Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices

KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar

An SME perspective on the MAA process (including e-dossier preparation and submission)

New Pharmacovigilance legislation. Post-authorisation safety studies. ENCePP Plenary meeting. 3 May 2012

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Health, Safety and Wellbeing Policy

Guide to Clinical Trial Applications

PROCEDURE FOR CONDUCTING PHARMACOVIGILANCE INSPECTIONS REQUESTED BY THE CVMP. Ad Hoc PhV Inspectors Working Group

Due diligence in the European medical devices industry

Health systems and products Medicinal products authorisations, EMA. PHARMACEUTICAL COMMITTEE 23 October st meeting SUMMARY RECORD

Review of EU Clinical Trial Directive. 15 May 2012 Mike Beckers Sidley Austin LLP, Brussels

PROPOSED DOCUMENT. Global Harmonization Task Force. Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices

Chapter 28 Pharmaceutical acquis (human and veterinary medicinal products)

Self-Evaluation/Audit Checklist for Food Supplement Manufacturers

The new EU clinical trial regulation 536/2014 : Low interventional trials

ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL

Clinical Trial Basics:

SQF 2000 Code. 6th Edition AUGUST A HACCP-Based Supplier Assurance Code for the Food Manufacturing and Distributing Industries

STANDARD OPERATING PROCEDURE

Conducting Clinical Trials of Investigational Medicinal Products

INFORMATION ON JAPANESE REGULATORY AFFAIRS

Regulatory and ethical requirements in medical devices studies. Turkey

AMF Position Compliance function requirements

Transcription:

RAC (EU) Examination Study Checklist Instructions: Use this checklist to track your progress when preparing for the RAC (EU) certification examination. When you begin your studying, each task statement and place a checkmark in the box that best describes your study needs for each task. If you are not familiar with or do not regularly perform the content in the listed task, you most likely need and should check the box. If the content listed is a task that you perform regularly as part of your job, you most likely need less and should check the Need box. Once you your of the content in the listed task, check the box. Domain I: Strategic Planning (approximately 31% of exam) Regulatory Framework 1. Determine the regulatory classification status in European Union markets where the product may be launched. 2. Monitor and assess the regulatory environment in European Union markets where the product may be launched (including additional national requirements such as legal status) and initiate changes within the company. 3. Investigate and communicate when it is necessary to request technical and scientific guidance from relevant organisations. 4. Evaluate regulatory requirements for markets outside of the European Union that recognize EU requirements. 5. Provide input to trade associations and standards organizations to influence the European regulatory environment (legislation, guidance documents, and standards). 6. Perform Competitor Surveillance (e.g., EPAR, SmPCs, claims, indications) to evaluate potential changes, is-sues, and strategies. 7. Contribute to in-house training programmes for company personnel to ensure regulatory and quality compliance. Regulatory Pathways and Options 8. Advise management on requirements and options for regulatory submissions, approvals, and conformity assessments (e.g., local, national, international options). 9. Advise management on timelines, risks and financial implications of the proposed regulatory strategy. 10. Investigate and communicate the availability of incentives (e.g., financial, data/market exclusivity) to support product development.

11. Develop effective regulatory submission strategies for timely product approval. 12. Advise colleagues on compliance with relevant regulatory legislation, guidelines, standards, etc. Health Economics 13. Provide input to and advise senior management regarding Comparative Effectiveness/Health Technology Assessment. 14. Advise senior management regarding pricing and reimbursement issues. Interaction with Other Companies 15. Advise senior management during product or company acquisitions and collaborations. 16. Conduct regulatory due diligence during acquisitions and collaborations. 17. In- and out-licensing of products from/to a third party. Crisis Management 18. Advise management regarding the regulatory impact of a crisis event (e.g., plant shut down) and propose a resolution strategy. 19. Participate in the development and functioning of the crisis management programme. Domain II: Designs and Development (approximately 36% of exam) Manufacturing/Quality (CMC) 1. Define and communicate regulatory requirements for the scope of manufacturing authorisations/quality system certifications (e.g., clinical trial supplies, operations allowed, pharmaceutical forms, design, manufacture, device types). 2. ness of production documentation to support CTA/MAA submissions/manufacturing transfer. 3. Ensure that available stability data supports intended shelflife of product. Nonclinical and Clinical Development 4. Advise sponsor of regulatory requirements for clinical trials/investigations. 5. Determine adequacy of nonclinical data and risk analysis to support approval to conduct clinical trials/investigations. 6. Identify national/local requirements and prepare clinical trials/investigations submissions to CA/EC. 7. Prepare or study information such as IMPD/technical file/design dossier, label, clinical investigation plan/protocol, case report form, investigators brochure, patient information letter, and informed consent to comply with local, regional, national, European, and international

regulatory requirements. 8. Interact with and coordinate the use of CROs, subcontractors, test facilities, and consultants. 9. Respond to questions/comments from CA/EC. 10. Ensure regulatory compliance of manufacture and release of investigational products for clinical use. 11. Ensure that reporting procedures are in place to report adverse events that occur during clinical trials/investigations to CA/EC. 12. clinical data from literature and other sources. 13. Report trial/investigation results to CA/EC. 14. Maintain authorisation for on-going clinical trials/investigations (e.g., amendments, annual reports, updates). 15. Evaluate need for and contribute to the development of Paediatric Investigation Plans/waivers/deferrals. Preregistration/CE Marking Interfacing 16. Evaluate need for and coordinate Protocol Assistance/Scientific Advice Meetings with CAs. 17. Liaise with project team to develop project plans including submission timelines, deliverables, etc. 18. Liaise with marketing/project team to develop target product profile and determine the claims that can and cannot be made based on available data. 19. Participate in audits/inspections by NBs/CAs and contribute to responses to audit findings as required. 20. Evaluate and communicate relevant legislation and guidelines (e.g., EMA, scientific, harmonized standards, and essential requirements). Registration/CE Marking 21. Ensure adequate documentation to support MAA/Technical File/Design dossier. (see test content outline for details) 22. Prepare MAA/Design Dossier/Technical File. 23. Submit MAA (incl. ectd requirements)/design Dossier to CA/NB. 24. Monitor /track submission progress (procedural timelines). 25. Respond to questions/comments from CA/NB. 26. Meet with CA/NB to negotiate during process. 27. Coordinate product information (i.e. label, carton, and leaflet/ifu) translations. 28. approval documents/certificates. Domain III: Postapproval (approximately 33% of exam)

Advertising/Promoting/Labelling 1. and approve revised labelling and claims, public communications, press releases, advertising, and promotional items for regulatory compliance. 2. Provide regulatory input to commercial and marketing strategies. 3. and evaluate advertising, labelling, and claims of competitors. 4. Provide regulatory input to tender applications (e.g., overview of licensing status, product quality, product shelf life, declaration of conformance). 5. Evaluate and communicate to management the implications of off-label use. Postmarketing Surveillance and Vigilance 6. Evaluate reports of product failures and complaints. 7. Write field safety notices and report product failures and recalls /field safety corrective actions to CAs. 8. Maintain vigilance and ensure post-market surveillance activities are conducted. 9. Ensure that Periodic Safety Update Reports (PSUR) are compiled and submitted to CAs according to regulatory timelines. 10. Ensure regulatory compliance of post-approval clinical studies. 11. Ensure implementation and monitor effectiveness of safety alerts, notifications, field safety corrective actions, and recalls. 12. Consider use of information gained in the post-market phase for broadening product indications. Supply Chain 13. Ensure compliance with regulatory requirements for supply, handling, distribution, import and export of materials. 14. regulatory aspects of supplier and distributor contracts (e.g., complaints, traceability, changes, etc.). Product-specific Crisis Management 15. Advise management regarding the regulatory impact of a crisis event (e.g., batch failure) 16. Advise management on regulatory implications of proposed crisis resolution strategies. Postapproval Regulatory Compliance 17. Advise the Management Representative/Qualified Person regarding regulatory requirements. 18. Ensure quality system SOPs meet regulatory requirements 19. Assess whether new or revised legislation, guidelines, monographs and harmonized standards affect certain functions, activities, or products 20. Initiate, monitor, document and submit changes where

applicable to ensure compliance with new or revised legislation, guidelines, monographs, and harmonised standards. 21. and monitor contractual obligations and agreements with NBs to ensure regulatory compliance. 22. Negotiate wording of audit findings.